Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

EuroIntervention 2023;18. DOI: 10.4244/EIJ-D-22-00526

Ton Slagboom
Ton Slagboom1, MD; Ralph Toelg2, MD; Bernhard Witzenbichler3, MD; Michael Haude4, MD; Monica Masotti5, MD; Rafael Ruiz Salmeron6, MD; Adam Ryszard Witkowski7, MD; Masaaki Uematus8, MD; Akihiko Takahashi9, MD; Ron Waksman10, MD; Shigeru Saito11, MD
1. Cardiology Unit, OLVG, Amsterdam, the Netherlands; 2. Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany; 3. Department of Cardiology and Pneumology, Helios Amper-Klinikum, Dachau, Germany; 4. Lukaskrankenhaus Medizinische Klinik I, Städtische Kliniken Neuss, Neuss, Germany; 5. Department of Cardiology, Hospital Clínic de Barcelona, Barcelona, Spain; 6. Haemodynamic Unit, Hospital Universitario Virgen Macarena, Seville, Spain; 7. National Institute of Cardiology, Warsaw, Poland; 8. Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan; 9. Sakurakai Takahashi Hospital, Kobe, Japan; 10. MedStar Health Research Institute, Washington, DC, USA; 11. Okinawa Tokushukai Shonan Kamakura General Hospital, Kamakura, Japan
Corrigendum Figures 1A and 1C of this article have been replaced in the online version. DP-SES has been replaced with DP-EES. 17th January 2022. Introduction A large body of evidence is available for biodegradable polymer stents1, but long-term data are scarce and predominantly evaluated for Caucasian subjects. The BIOFLOW-IV trial aimed to provide additional data, comparing the safety and effectiveness of the ultrathin Orsiro biodegradable polymer sirolimus-eluting stent (BP-SES; Biotronik) with the XIENCE Prime/XIENCE Xpedition durable polymer everolimus-eluting stent (DP-EES; Abbott). We herein report final 5-year data.

Methods The BIOFLOW-IV study has been described previously2, and is registered at ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clinical trialsdrug-eluting stentmiscellaneous
Read next article
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure

Latest news

AHEAD OF PRINT
Single antiplatelet therapy directly after PCI
FREE ARTICLE - Niels M.R. van der Sangen et al
February 3, 2023
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023